Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 52 entries
Sorted by: Best Match Show Resources per page
Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Hakim M, Walia H, Rafiq M, Grannell T, Cartabuke RS, Tobias JD.
PMID: 27453703
J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):247-51. doi: 10.5863/1551-6776-21.3.247.

OBJECTIVES: The current study compared the amount of oxymetazoline delivered by various anesthesia providers when holding the bottle in the upright and inverted position. Additionally, the amount delivered from a full bottle and a half-full bottle was also investigated.METHODS:...

Cite
Hakim M, Walia H, Rafiq M, et al. Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume. J Pediatr Pharmacol Ther. 2016;21(3):247-51doi: 10.5863/1551-6776-21.3.247.
Hakim, M., Walia, H., Rafiq, M., Grannell, T., Cartabuke, R. S., & Tobias, J. D. (2016). Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 21(3), 247-51. https://doi.org/10.5863/1551-6776-21.3.247
Hakim, Mumin, et al. "Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 21,3 (2016): 247-51. doi: https://doi.org/10.5863/1551-6776-21.3.247
Hakim M, Walia H, Rafiq M, Grannell T, Cartabuke RS, Tobias JD. Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume. J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):247-51. doi: 10.5863/1551-6776-21.3.247. PMID: 27453703; PMCID: PMC4956333.
Copy Download .nbib Format: NLM
Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists' Views and Experiences.

Pharmacy (Basel, Switzerland)

Gauld N, Sullivan T.
PMID: 30004399
Pharmacy (Basel). 2018 Jul 02;6(3). doi: 10.3390/pharmacy6030059.

The aim of this paper was to explore pharmacists' views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists' views on the reclassification of the shingles vaccine and...

Cite
Gauld N, Sullivan T. Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists' Views and Experiences. Pharmacy (Basel). 2018;6(3)doi: 10.3390/pharmacy6030059.
Gauld, N., & Sullivan, T. (2018). Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists' Views and Experiences. Pharmacy (Basel, Switzerland), 6(3), . https://doi.org/10.3390/pharmacy6030059
Gauld, Natalie, and Sullivan, Tracey. "Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists' Views and Experiences." Pharmacy (Basel, Switzerland) vol. 6,3 (2018). doi: https://doi.org/10.3390/pharmacy6030059
Gauld N, Sullivan T. Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists' Views and Experiences. Pharmacy (Basel). 2018 Jul 02;6(3). doi: 10.3390/pharmacy6030059. PMID: 30004399; PMCID: PMC6165278.
Copy Download .nbib Format: NLM
Advances in the Diagnosis and Management of Influenza.

Current infectious disease reports

Jefferson T.
PMID: 12015912
Curr Infect Dis Rep. 2002 Jun;4(3):206-210. doi: 10.1007/s11908-002-0080-5.

Vaccines are the mainstay of influenza prevention. In the treatment of a likely or certain case of influenza, ion channel inhibitors (amantadine and rimantadine) and neuraminidase inhibitors (oseltamivir and zanamivir) can be effective in reducing the duration of illness...

Cite
Jefferson T. Advances in the Diagnosis and Management of Influenza. Curr Infect Dis Rep. 2002;4(3):206-210doi: 10.1007/s11908-002-0080-5.
Jefferson, T. (2002). Advances in the Diagnosis and Management of Influenza. Current infectious disease reports, 4(3), 206-210. https://doi.org/10.1007/s11908-002-0080-5
Jefferson, Tom. "Advances in the Diagnosis and Management of Influenza." Current infectious disease reports vol. 4,3 (2002): 206-210. doi: https://doi.org/10.1007/s11908-002-0080-5
Jefferson T. Advances in the Diagnosis and Management of Influenza. Curr Infect Dis Rep. 2002 Jun;4(3):206-210. doi: 10.1007/s11908-002-0080-5. PMID: 12015912; PMCID: PMC7088758.
Copy Download .nbib Format: NLM
Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study.

Contemporary clinical dentistry

Lahoti KS.
PMID: 27041896
Contemp Clin Dent. 2016 Jan-Mar;7(1):27-30. doi: 10.4103/0976-237X.177104.

BACKGROUND: Chemical agents used for gingival retraction affects the smear layer.AIM: To determine the effect of three different chemical agents used for gingival retraction systems on smear layer.MATERIALS AND METHODS: Four human premolars were prepared using air-rotor with air-water...

Cite
Lahoti KS. Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study. Contemp Clin Dent. 2016;7(1):27-30doi: 10.4103/0976-237X.177104.
Lahoti, K. S. (2016). Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study. Contemporary clinical dentistry, 7(1), 27-30. https://doi.org/10.4103/0976-237X.177104
Lahoti, Krishna Shivraj. "Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study." Contemporary clinical dentistry vol. 7,1 (2016): 27-30. doi: https://doi.org/10.4103/0976-237X.177104
Lahoti KS. Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study. Contemp Clin Dent. 2016 Jan-Mar;7(1):27-30. doi: 10.4103/0976-237X.177104. PMID: 27041896; PMCID: PMC4792050.
Copy Download .nbib Format: NLM
Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study.

Clinical and experimental otorhinolaryngology

Şahin Mİ, Kökoğlu K, Güleç Ş, Ketenci İ, Ünlü Y.
PMID: 27459198
Clin Exp Otorhinolaryngol. 2017 Jun;10(2):158-163. doi: 10.21053/ceo.2016.00563. Epub 2016 Jul 27.

OBJECTIVES: To identify the optimal pharmacological method of preparing patients for nasal endoscopy.METHODS: Twenty healthy volunteers were enrolled in this prospective, randomized, double-blind study. Four types of medications were applied in their nostrils with binary combinations of spray bottles...

Cite
Şahin Mİ, Kökoğlu K, Güleç Ş, et al. Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study. Clin Exp Otorhinolaryngol. 2016;10(2):158-163doi: 10.21053/ceo.2016.00563.
Şahin, M. �. �., Kökoğlu, K., Güleç, �. �., Ketenci, �. �., & Ünlü, Y. (2017). Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study. Clinical and experimental otorhinolaryngology, 10(2), 158-163. https://doi.org/10.21053/ceo.2016.00563
Şahin, Mehmet İlhan, et al. "Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study." Clinical and experimental otorhinolaryngology vol. 10,2 (2017): 158-163. doi: https://doi.org/10.21053/ceo.2016.00563
Şahin Mİ, Kökoğlu K, Güleç Ş, Ketenci İ, Ünlü Y. Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study. Clin Exp Otorhinolaryngol. 2017 Jun;10(2):158-163. doi: 10.21053/ceo.2016.00563. Epub 2016 Jul 27. PMID: 27459198; PMCID: PMC5426394.
Copy Download .nbib Format: NLM
Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?.

The Journal of clinical and aesthetic dermatology

Del Rosso JQ.
PMID: 29104721
J Clin Aesthet Dermatol. 2017 Jul;10(7):28-32. Epub 2017 Jul 01.

The presence of vasoactivity in rosacea-affected skin led to the development of two topical α-adrenergic receptor agonists, brimonidine tartrate 0.5% gel and oxymetazoline hydrochloride 1% cream, both approved by the United States Food and Drug Administration for treatment of...

Cite
Del Rosso JQ. Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?. J Clin Aesthet Dermatol. 2017;10(7):28-32
Del Rosso, J. Q. (2017). Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?. The Journal of clinical and aesthetic dermatology, 10(7), 28-32.
Del Rosso, James Q. "Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?." The Journal of clinical and aesthetic dermatology vol. 10,7 (2017): 28-32.
Del Rosso JQ. Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?. J Clin Aesthet Dermatol. 2017 Jul;10(7):28-32. Epub 2017 Jul 01. PMID: 29104721; PMCID: PMC5605221.
Copy Download .nbib Format: NLM
Systemic side effects of locally used oxymetazoline.

International journal of clinical and experimental medicine

Dokuyucu R, Gokce H, Sahan M, Sefil F, Tas ZA, Tutuk O, Ozturk A, Tumer C, Cevik C.
PMID: 25932218
Int J Clin Exp Med. 2015 Feb 15;8(2):2674-8. eCollection 2015.

OBJECTIVES: The object of the study is to experimentally investigate the possible systemic side effects of Oxymetazoline including its nasal spray which has been in use for a long time both by the physicians and patients. There is no...

Cite
Dokuyucu R, Gokce H, Sahan M, et al. Systemic side effects of locally used oxymetazoline. Int J Clin Exp Med. 2015;8(2):2674-8
Dokuyucu, R., Gokce, H., Sahan, M., Sefil, F., Tas, Z. A., Tutuk, O., Ozturk, A., Tumer, C., & Cevik, C. (2015). Systemic side effects of locally used oxymetazoline. International journal of clinical and experimental medicine, 8(2), 2674-8.
Dokuyucu, Recep, et al. "Systemic side effects of locally used oxymetazoline." International journal of clinical and experimental medicine vol. 8,2 (2015): 2674-8.
Dokuyucu R, Gokce H, Sahan M, Sefil F, Tas ZA, Tutuk O, Ozturk A, Tumer C, Cevik C. Systemic side effects of locally used oxymetazoline. Int J Clin Exp Med. 2015 Feb 15;8(2):2674-8. eCollection 2015. PMID: 25932218; PMCID: PMC4402865.
Copy Download .nbib Format: NLM
Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review.

International journal of pediatric otorhinolaryngology

Macmillan AJ, Phoon KM, Edafe O.
PMID: 34942425
Int J Pediatr Otorhinolaryngol. 2021 Dec 17;153:111010. doi: 10.1016/j.ijporl.2021.111010. Epub 2021 Dec 17.

OBJECTIVES: Topical intranasal decongestants are essential in nasal surgery to improve operative field. There are concerns regarding safety in paediatric population. Data on safety and safe dosage are limited. This systematic review evaluated the literature on safety and dosage...

Cite
Macmillan AJ, Phoon KM, Edafe O. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. Int J Pediatr Otorhinolaryngol. 2021;153:111010doi: 10.1016/j.ijporl.2021.111010.
Macmillan, A. J., Phoon, K. M., & Edafe, O. (2021). Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. International journal of pediatric otorhinolaryngology, 153111010. https://doi.org/10.1016/j.ijporl.2021.111010
Macmillan, A J, et al. "Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review." International journal of pediatric otorhinolaryngology vol. 153 (2021): 111010. doi: https://doi.org/10.1016/j.ijporl.2021.111010
Macmillan AJ, Phoon KM, Edafe O. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. Int J Pediatr Otorhinolaryngol. 2021 Dec 17;153:111010. doi: 10.1016/j.ijporl.2021.111010. Epub 2021 Dec 17. PMID: 34942425.
Copy Download .nbib Format: NLM
Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review.

International journal of pediatric otorhinolaryngology

Macmillan AJ, Phoon KM, Edafe O.
PMID: 34942425
Int J Pediatr Otorhinolaryngol. 2021 Dec 17;153:111010. doi: 10.1016/j.ijporl.2021.111010. Epub 2021 Dec 17.

OBJECTIVES: Topical intranasal decongestants are essential in nasal surgery to improve operative field. There are concerns regarding safety in paediatric population. Data on safety and safe dosage are limited. This systematic review evaluated the literature on safety and dosage...

Cite
Macmillan AJ, Phoon KM, Edafe O. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. Int J Pediatr Otorhinolaryngol. 2021;153:111010doi: 10.1016/j.ijporl.2021.111010.
Macmillan, A. J., Phoon, K. M., & Edafe, O. (2021). Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. International journal of pediatric otorhinolaryngology, 153111010. https://doi.org/10.1016/j.ijporl.2021.111010
Macmillan, A J, et al. "Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review." International journal of pediatric otorhinolaryngology vol. 153 (2021): 111010. doi: https://doi.org/10.1016/j.ijporl.2021.111010
Macmillan AJ, Phoon KM, Edafe O. Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery - A systematic review. Int J Pediatr Otorhinolaryngol. 2021 Dec 17;153:111010. doi: 10.1016/j.ijporl.2021.111010. Epub 2021 Dec 17. PMID: 34942425.
Copy Download .nbib Format: NLM
Epistaxis management on COVID-19-positive patients: Our early case experience and treatment.

Clinical case reports

Bathula SSR, Patrick T, Srikantha L.
PMID: 32837722
Clin Case Rep. 2020 Jul 21; doi: 10.1002/ccr3.3137. Epub 2020 Jul 21.

Epistaxis management on COVID-19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with...

Cite
Bathula SSR, Patrick T, Srikantha L. Epistaxis management on COVID-19-positive patients: Our early case experience and treatment. Clin Case Rep. 2020;doi: 10.1002/ccr3.3137.
Bathula, S. S. R., Patrick, T., & Srikantha, L. (2020). Epistaxis management on COVID-19-positive patients: Our early case experience and treatment. Clinical case reports, . https://doi.org/10.1002/ccr3.3137
Bathula, Samba Siva R, et al. "Epistaxis management on COVID-19-positive patients: Our early case experience and treatment." Clinical case reports vol. (2020). doi: https://doi.org/10.1002/ccr3.3137
Bathula SSR, Patrick T, Srikantha L. Epistaxis management on COVID-19-positive patients: Our early case experience and treatment. Clin Case Rep. 2020 Jul 21; doi: 10.1002/ccr3.3137. Epub 2020 Jul 21. PMID: 32837722; PMCID: PMC7404437.
Copy Download .nbib Format: NLM
Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline.

Optometry and vision science : official publication of the American Academy of Optometry

Cooper J, Yang D.
PMID: 34510144
Optom Vis Sci. 2021 Nov 01;98(11):1317-1320. doi: 10.1097/OPX.0000000000001800.

SIGNIFICANCE: Ptosis is often the hallmark finding in ocular and general myasthenia gravis. Reduction of ptosis has been achieved with oral and topical ocular medications. However, these medications can result in systemic and ocular adverse effects. A novel eye...

Cite
Cooper J, Yang D. Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline. Optom Vis Sci. 2021;98(11):1317-1320doi: 10.1097/OPX.0000000000001800.
Cooper, J., & Yang, D. (2021). Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline. Optometry and vision science : official publication of the American Academy of Optometry, 98(11), 1317-1320. https://doi.org/10.1097/OPX.0000000000001800
Cooper, Jeffrey, and Yang, Danica. "Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline." Optometry and vision science : official publication of the American Academy of Optometry vol. 98,11 (2021): 1317-1320. doi: https://doi.org/10.1097/OPX.0000000000001800
Cooper J, Yang D. Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline. Optom Vis Sci. 2021 Nov 01;98(11):1317-1320. doi: 10.1097/OPX.0000000000001800. PMID: 34510144.
Copy Download .nbib Format: NLM
Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial.

The Journal of dermatological treatment

Agamia N, Essawy M, Kassem A.
PMID: 32602755
J Dermatolog Treat. 2020 Jul 07;1-6. doi: 10.1080/09546634.2020.1789045. Epub 2020 Jul 07.

BACKGROUND: Post-inflammatory erythema (PIE) is a common sequalae of acne inflammation, persistent post acne erythema (PAE) is cosmetically unacceptable and sometimes its complete clearance could not be achieved. Oxymetazoline (OXZ) is a synthetic, direct-acting, sympathomimetic agonist that is highly...

Cite
Agamia N, Essawy M, Kassem A. Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial. J Dermatolog Treat. 2020;1-6doi: 10.1080/09546634.2020.1789045.
Agamia, N., Essawy, M., & Kassem, A. (2020). Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial. The Journal of dermatological treatment, 1-6. https://doi.org/10.1080/09546634.2020.1789045
Agamia, Naglaa, et al. "Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial." The Journal of dermatological treatment vol. (2020): 1-6. doi: https://doi.org/10.1080/09546634.2020.1789045
Agamia N, Essawy M, Kassem A. Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial. J Dermatolog Treat. 2020 Jul 07;1-6. doi: 10.1080/09546634.2020.1789045. Epub 2020 Jul 07. PMID: 32602755.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 52 entries